Morgan Stanley lowered the firm’s price target on Vital Farms (VITL) to $45 from $48 and keeps an Overweight rating on the shares. At its investor day, Vital updated its long-term algorithm with above-consensus targets, though this was overshadowed and yesterday’s stock reaction was driven by an “unexpected” FY25 revenue guidance cut, the analyst tells investors. However, the firm sees the event providing greater visibility into “a long, underappreciated growth runway,” the analyst added.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
- Vital Farms: Long-Term Growth Potential Outweighs Minor Short-Term Revenue Adjustment
- Morning Movers: Vital Farms dips after cutting FY25 revenue view
- Vital Farms Sets Ambitious 2030 Financial Targets
- Vital Farms issues long-term financial targets ahead of investor day